JP Morgan Maintains Overweight on Zoetis, Lowers Price Target to $115

Benzinga Newsdesk www.benzinga.com Negative 79.8%

Neg 79.8% Neu 0% Pos 0%

JP Morgan analyst Chris Schott maintains Zoetis (NYSE:ZTS) with a Overweight and lowers the price target from $130 to $115.